Age-associated clonal B cells drive B cell lymphoma in mice

Nat Aging. 2024 Oct;4(10):1403-1417. doi: 10.1038/s43587-024-00671-7. Epub 2024 Aug 8.

Abstract

Although cancer is an age-related disease, how the processes of aging contribute to cancer progression is not well understood. In this study, we uncovered how mouse B cell lymphoma develops as a consequence of a naturally aged system. We show here that this malignancy is associated with an age-associated clonal B cell (ACBC) population that likely originates from age-associated B cells. Driven by c-Myc activation, promoter hypermethylation and somatic mutations, IgM+ ACBCs clonally expand independently of germinal centers and show increased biological age. ACBCs become self-sufficient and support malignancy when transferred into young recipients. Inhibition of mTOR or c-Myc in old mice attenuates pre-malignant changes in B cells during aging. Although the etiology of mouse and human B cell lymphomas is considered distinct, epigenetic changes in transformed mouse B cells are enriched for changes observed in human B cell lymphomas. Together, our findings characterize the spontaneous progression of cancer during aging through both cell-intrinsic and microenvironmental changes and suggest interventions for its prevention.

MeSH terms

  • Aging* / genetics
  • Animals
  • B-Lymphocytes* / immunology
  • B-Lymphocytes* / metabolism
  • B-Lymphocytes* / pathology
  • Clone Cells
  • DNA Methylation
  • Epigenesis, Genetic
  • Humans
  • Lymphoma, B-Cell* / genetics
  • Lymphoma, B-Cell* / immunology
  • Lymphoma, B-Cell* / pathology
  • Mice
  • Mutation
  • Proto-Oncogene Proteins c-myc / genetics
  • Proto-Oncogene Proteins c-myc / metabolism
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Proto-Oncogene Proteins c-myc
  • TOR Serine-Threonine Kinases